Willow Historical Balance Sheet

WLLW Stock  CAD 0.07  0.01  6.25%   
Trend analysis of Willow Biosciences balance sheet accounts such as Other Current Liabilities of 395.6 K, Total Current Liabilities of 944 K, Total Stockholder Equity of 3.8 M or Common Stock Total Equity of 100.4 M provides information on Willow Biosciences' total assets, liabilities, and equity, which is the actual value of Willow Biosciences to its prevalent stockholders. By breaking down trends over time using Willow Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Willow Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Willow Biosciences is a good buy for the upcoming year.

Willow Biosciences Inventory

244,699

  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Willow Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Willow Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Willow Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Willow Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Willow currently owns. An asset can also be divided into two categories, current and non-current.

Willow Biosciences Balance Sheet Chart

At this time, Willow Biosciences' Accounts Payable is very stable compared to the past year. As of the 13th of December 2024, Cash is likely to grow to about 4 M, while Total Current Liabilities is likely to drop about 944 K.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Accumulated Other Comprehensive Income

Gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized.
Most accounts from Willow Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Willow Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Willow Biosciences' Accounts Payable is very stable compared to the past year. As of the 13th of December 2024, Cash is likely to grow to about 4 M, while Total Current Liabilities is likely to drop about 944 K.
 2021 2022 2023 2024 (projected)
Total Current Liabilities1.4M1.7M1.8M944.0K
Other Current Liabilities757K1.1M320K395.6K

Willow Biosciences balance sheet Correlations

0.340.57-0.450.730.540.540.510.71-0.670.170.670.70.820.670.650.710.140.450.470.570.0-0.080.840.60.47
0.340.5-0.660.50.620.510.660.63-0.530.830.560.580.330.210.450.590.090.670.570.470.29-0.130.410.040.57
0.570.5-0.470.490.60.20.60.88-0.870.320.870.890.440.070.490.880.270.550.560.57-0.06-0.130.560.350.55
-0.45-0.66-0.47-0.88-0.98-0.4-0.99-0.570.5-0.31-0.56-0.59-0.26-0.2-0.92-0.61-0.45-0.43-0.27-0.89-0.480.3-0.640.0-0.37
0.730.50.49-0.880.90.460.890.61-0.540.140.60.620.550.470.950.630.350.440.350.910.51-0.180.860.310.38
0.540.620.6-0.980.90.390.990.66-0.60.260.660.690.360.220.930.70.460.480.350.930.41-0.290.710.060.46
0.540.510.2-0.40.460.390.390.65-0.60.390.610.590.520.880.390.60.070.740.610.150.02-0.130.440.480.72
0.510.660.6-0.990.890.990.390.66-0.60.320.660.690.320.20.920.70.450.490.350.920.44-0.290.670.060.44
0.710.630.88-0.570.610.660.650.66-0.970.440.980.980.60.490.580.980.250.80.740.52-0.03-0.160.650.50.78
-0.67-0.53-0.870.5-0.54-0.6-0.6-0.6-0.97-0.35-1.0-0.99-0.47-0.47-0.57-0.99-0.2-0.67-0.59-0.460.130.14-0.59-0.55-0.69
0.170.830.32-0.310.140.260.390.320.44-0.350.360.380.130.120.090.38-0.160.530.470.10.180.04-0.02-0.010.43
0.670.560.87-0.560.60.660.610.660.98-1.00.360.990.480.470.620.990.230.70.610.52-0.06-0.160.620.530.7
0.70.580.89-0.590.620.690.590.690.98-0.990.380.990.490.440.641.00.250.670.580.56-0.08-0.190.630.490.67
0.820.330.44-0.260.550.360.520.320.6-0.470.130.480.490.610.340.50.10.550.720.350.030.050.740.590.57
0.670.210.07-0.20.470.220.880.20.49-0.470.120.470.440.610.360.45-0.050.520.450.10.02-0.020.530.650.51
0.650.450.49-0.920.950.930.390.920.58-0.570.090.620.640.340.360.660.40.310.150.920.38-0.260.770.180.3
0.710.590.88-0.610.630.70.60.70.98-0.990.380.991.00.50.450.660.260.670.580.57-0.07-0.190.650.490.67
0.140.090.27-0.450.350.460.070.450.25-0.2-0.160.230.250.1-0.050.40.260.30.150.47-0.07-0.410.4-0.160.22
0.450.670.55-0.430.440.480.740.490.8-0.670.530.70.670.550.520.310.670.30.920.320.11-0.230.480.260.92
0.470.570.56-0.270.350.350.610.350.74-0.590.470.610.580.720.450.150.580.150.920.230.11-0.020.450.370.87
0.570.470.57-0.890.910.930.150.920.52-0.460.10.520.560.350.10.920.570.470.320.230.47-0.30.770.010.27
0.00.29-0.06-0.480.510.410.020.44-0.030.130.18-0.06-0.080.030.020.38-0.07-0.070.110.110.470.210.15-0.04-0.06
-0.08-0.13-0.130.3-0.18-0.29-0.13-0.29-0.160.140.04-0.16-0.190.05-0.02-0.26-0.19-0.41-0.23-0.02-0.30.21-0.250.38-0.12
0.840.410.56-0.640.860.710.440.670.65-0.59-0.020.620.630.740.530.770.650.40.480.450.770.15-0.250.420.46
0.60.040.350.00.310.060.480.060.5-0.55-0.010.530.490.590.650.180.49-0.160.260.370.01-0.040.380.420.27
0.470.570.55-0.370.380.460.720.440.78-0.690.430.70.670.570.510.30.670.220.920.870.27-0.06-0.120.460.27
Click cells to compare fundamentals

Willow Biosciences Account Relationship Matchups

Willow Biosciences balance sheet Accounts

201920202021202220232024 (projected)
Total Current Liabilities1.8M1.6M1.4M1.7M1.8M944.0K
Total Stockholder Equity22.0M(559K)29.7M16.4M3.4M3.8M
Retained Earnings(53.8M)(87.7M)(93.8M)(108.7M)(121.7M)(115.6M)
Common Stock Shares Outstanding72.1M82.0M120.0M123.7M124.2M130.5M
Total Liab11.9M22.4M5.3M1.8M3.2M2.5M
Common Stock72.6M83.2M118.0M118.1M118.2M124.1M
Total Assets33.9M21.9M35.0M18.1M6.7M7.2M
Net Debt(18.4M)(15.0M)(29.3M)(10.3M)(989K)(1.0M)
Accounts Payable1.1M978K757K1.1M635K650.4K
Cash19.6M15.9M30.1M11.0M3.1M4.0M
Cash And Short Term Investments19.7M15.9M30.1M15.0M3.2M4.2M
Net Receivables654.2K289K89K282K166K127.4K
Liabilities And Stockholders Equity33.9M21.9M35.0M18.1M6.7M7.2M
Other Current Assets201.3K561K679K643K619K650.0K
Total Current Assets20.8M17.0M31.3M16.2M4.2M4.5M
Other Stockholder Equity3.3M4.3M5.9M7.3M7.3M6.9M
Property Plant And Equipment Net6.7M4.7M3.7M1.9M2.4M2.7M
Non Current Assets Total13.1M4.8M3.7M1.9M2.5M3.2M
Property Plant Equipment6.5M4.7M3.6M1.9M2.2M2.6M
Short Term Investments90.9K561K679K4.0M20K19K
Net Tangible Assets835.0K15.5M(624K)29.6M34.1M35.8M

Pair Trading with Willow Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Willow Stock

  0.84CMC Cielo Waste Solutions Earnings Call This WeekPairCorr

Moving against Willow Stock

  0.8LQWD LQwD FinTech CorpPairCorr
  0.77MATE Blockmate VenturesPairCorr
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Willow Stock

Balance Sheet is a snapshot of the financial position of Willow Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Willow Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Willow Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Willow currently owns. An asset can also be divided into two categories, current and non-current.